ABSTRACT
The fallopian tube is a frequent site of metastasis. Ovarian, endometrial, and cervical cancer metastasis are reported in up to 50%, 12%, and 4%of the patients, respectively (1-4). The importance of these implants has been recognized by the FIGO that has therefore introduced adnexal pathologic examination as part of the ovarian staging system. Therefore the clinical relevance of fallopian tube metastasis has already been discussed in the chapter on the primary ovarian tumors. For these reasons, in the following chapter, we are going to discuss only primary disease.
